The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Cancer treatment has long faced a challenging trade-off: therapies strong enough to eliminate tumors often cause severe side effects. One promising solution involves cytokines, natural proteins that ...

The FDA’s decision to clear the Apple Watch is a big deal because it shows they are open to new kinds of medical devices. It ...

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

New fluorescent drug lights up nerve tissue under special imaging equipment, giving surgeons a visual edge during procedure.

The GOP tax bill repeals the Inflation Reduction Act’s price controls for drugs for rare diseases.

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

When surgeons dissect tissue to remove a tumor or make a repair, they must work cautiously, relying on electrophysical ...

Regeneron Pharmaceuticals has received accelerated FDA approval for Lynozyfic, a new bispecific antibody treatment for adults with relapsed or refractory multiple myeloma who have undergone at least ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.